000 01506 a2200421 4500
005 20250516124549.0
264 0 _c20130221
008 201302s 0 0 eng d
022 _a1469-493X
024 7 _a10.1002/14651858.CD008990.pub2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBreederveld, Roelf S
245 0 0 _aRecombinant human growth hormone for treating burns and donor sites.
_h[electronic resource]
260 _bThe Cochrane database of systematic reviews
_cDec 2012
300 _aCD008990 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAnabolic Agents
_xtherapeutic use
650 0 4 _aBody Surface Area
650 0 4 _aBurns
_xdrug therapy
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aHuman Growth Hormone
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aMiddle Aged
650 0 4 _aOxandrolone
_xtherapeutic use
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aRecombinant Proteins
_xtherapeutic use
650 0 4 _aTransplant Donor Site
650 0 4 _aWound Healing
_xdrug effects
650 0 4 _aYoung Adult
700 1 _aTuinebreijer, Wim E
773 0 _tThe Cochrane database of systematic reviews
_gvol. 12
_gp. CD008990
856 4 0 _uhttps://doi.org/10.1002/14651858.CD008990.pub2
_zAvailable from publisher's website
999 _c22342108
_d22342108